Related Experiment Video
Updated: Aug 5, 2026

Intramuscular Transplantation of Human Pluripotent Stem Cell-derived Pancreatic Endocrine Cells in Mice
Published on: April 10, 2026
Beyond Insulin: Why Type 1 Diabetes Mellitus Needs More?
Huajing Ni1, Jennifer R Snaith2, Jerry R Greenfield2
1Translational Diabetes Lab, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia; St. Vincent's Healthcare Campus, School of Clinical Medicine, Faculty of Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.
Abstract:
A century after the discovery of insulin, people with type 1 diabetes continue to experience elevated cardiovascular risk and associated mortality, incompletely explained by dysglycemia and traditional risk factors. There is increasing recognition of the contributions of glycemic variability, insulin-related weight gain, insulin resistance and other hormonal disturbances to this risk, necessitating additional agents targeting these pathways. This article explores these mechanisms and provides an overview of current available agents. Finally, we highlight the sparsity of data on long-term outcomes and hard cardiovascular endpoints.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes II: Pathophysiology
Diabetes Mellitus: Type 2 and Gestational
Type I Diabetes I: Introduction
Type II Diabetes I: Introduction
Type II Diabetes II: Pathophysiology